MMP2 and osteosarcoma: We previously demonstrated that lipophilic statins (atorvastatin, simvastatin, or cerivastatin) trigger caspases-dependent apoptosis in osteosarcoma cells [43] and reduce cell invasiveness through inhibition of a RhoA GTPase-JNK-MMP2 cascade [10].